Authored by: Sriram Chakravadhanula Art by: Carol Zhang In March 2024, the U.S. Food and Drug Administration (FDA) approved GLP-1 medication for heart disease, in addition to its application for diabetes, leading to a massive increase in GLP-1 users. The United States became the largest market for Ozempic and Wegovy supplier, Novo Nordisk, with over 71% of the Company’s drug sales come from the United States[1]. As Senator Warren revealed, Ozempic is priced at $936 in the US

Authored by: Srijita Kommaraju On a summer vacation to my home country, India, I was astonished by how casually my relatives manage their health. Heaping plates full of white rice, rotis, and curries were eaten thoroughly, followed by metformin tablets and insulin injections. This was so normalized that no one thought to question it. And for a while, I didn’t either. But then it hit me. Everywhere I looked, my uncles, grandparents, and even strangers passing down the street

Authored by: Sophie Rinzler Art by: Stefanie Chen From the moment a clinician turns toward a keyboard, something essential is lost: the full gaze, the clarifying nod, the pause that signals undivided attention. As electronic health record (EHR) demands expand, human medical scribes are increasingly replaced by artificial intelligence (AI). Companies like Abridge and Nuance promise to restore clinicians’ focus on patients, reducing burnout and reclaiming time for care. Yet beh